Santhera Pharmaceuticals Holding (SPHDF) Q4 2021 Earnings Report
SPHDF Q4 2021 EPS Results
- Actual EPS
- -$9.15
- Consensus EPS
- -$7.60
- Beat/Miss
- Missed by -$1.55
- One Year Ago EPS
- -$27.70
SPHDF Q4 2021 Revenue Results
- Actual Revenue
- -$7.33M
- Expected Revenue
- $2.50M
- Beat/Miss
- Missed by -$9.83M
- YoY Revenue Growth
- -184.16%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/11/2022
- Time
- TBA
- Conference Call
- Friday, March 11, 2022
SPHDF Upcoming Earnings
Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
SPHDF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 29, 2027 | 2026 (Q4) | ―- | -0.52 | ― | ― |
| Sep 30, 2026 | 2026 (Q2) | 0.20-1.81 | -0.45 | -305.41% (-1.36) | |
| Apr 28, 2026 | 2025 (Q4) | -0.52-0.52 | -0.89 | 41.89% (+0.37) | |
| Sep 23, 2025 | 2025 (Q2) | -0.72-3.66 | -1.63 | -125.19% (-2.03) | |
| Apr 29, 2025 | 2024 (Q4) | -0.89-0.89 | 8.75 | -110.18% (-9.64) | |
| Sep 12, 2024 | 2024 (Q2) | -1.13-1.63 | -1.9 | 14.56% (+0.28) | |
| Apr 25, 2024 | 2023 (Q4) | ―8.75 | -2.56 | 441.31% (+11.32) | |
| Sep 07, 2023 | 2023 (Q2) | -1.90-1.90 | -6.31 | 69.85% (+4.41) | |
| Apr 27, 2023 | 2022 (Q4) | ―-2.56 | -2.77 | 7.39% (+0.20) | |
| Oct 31, 2022 | 2022 (Q2) | ―-6.31 | -11.1 | 43.19% (+4.80) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed